Schweinfurthin Natural Products Induce Regression of Murine Melanoma and Pair With Anti-Pd-1 Therapy to Facilitate Durable Tumor Immunity

OncoImmunology- United States

doi 10.1080/2162402x.2018.1539614

Full Text

Abstract

Available in

Date

Authors

Publisher

Informa UK Limited

Related search

Safety and Tumor Responses With Lambrolizumab (Anti–PD-1) in Melanoma

New England Journal of Medicine
Medicine
2013English

Regorafenib Promotes Anti-Tumor Immunity via Inhibiting PD-L1 and IDO1 Expression in Melanoma

Clinical Cancer Research
Cancer ResearchOncology
2019English

CD4+ T-Cell Immunity in the Peripheral Blood Correlates With Response to Anti-Pd-1 Therapy

Cancer immunology research
Cancer ResearchImmunology
2019English

Factors Influencing the Efficacy of Anti-Pd-1 Therapy in Chinese Patients With Advanced Melanoma

Journal of Oncology
Oncology
2019English

Propranolol Induces a Favourable Shift of Anti-Tumor Immunity in a Murine Spontaneous Model of Melanoma

Oncotarget
Oncology
2016English

Ineffective Anti PD-1 Therapy After BRAF Inhibitor Failure in Advanced Melanoma

BMC Cancer
Cancer ResearchOncologyGenetics
2018English

Melanoma-Specific MHC-II Expression Represents a Tumour-Autonomous Phenotype and Predicts Response to Anti-Pd-1/Pd-L1 Therapy

Nature Communications
AstronomyGeneticsMolecular BiologyBiochemistryChemistryPhysics
2016English

Transcriptional Mechanisms of Resistance to Anti–PD-1 Therapy

Clinical Cancer Research
Cancer ResearchOncology
2017English

Stimulation of Anti-Tumor Immunity by Photodynamic Therapy

Expert Review of Clinical Immunology
AllergyImmunology
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy